{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:50:22Z","timestamp":1791345022161,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"The University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["2021-00060204"],"award-info":[{"award-number":["2021-00060204"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Robert Hickey Chair in Clinical Care Endowment"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["#R03-AI-166285"],"award-info":[{"award-number":["#R03-AI-166285"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jinf.2025.106535","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:16:05Z","timestamp":1750076165000},"page":"106535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Blastemia portrays a poor prognosis in acute leukemia patients with invasive pulmonary aspergillosis"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-3405","authenticated-orcid":false,"given":"Sung-Yeon","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-7256","authenticated-orcid":false,"given":"Sebastian","family":"Wurster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bazinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8051-2940","authenticated-orcid":false,"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jinf.2025.106535_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/dkx423","article-title":"Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial","volume":"73","author":"Kontoyiannis","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2025.106535_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","author":"Herbrecht","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"10020","key":"10.1016\/j.jinf.2025.106535_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"10273","key":"10.1016\/j.jinf.2025.106535_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jinf.2025.106535_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.2019001239","article-title":"How I treat acute myeloid leukemia in the era of new drugs","volume":"135","author":"DiNardo","year":"2020","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jinf.2025.106535_bib6","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/bloodadvances.2019000930","article-title":"Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents","volume":"3","author":"Aldoss","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jinf.2025.106535_bib7","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/cid\/ciy406","article-title":"Breakthrough fungal infections in patients with leukemia receiving isavuconazole","volume":"67","author":"Rausch","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106535_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough invasive fungal infections in patients with high-risk hematological disorders receiving voriconazole and posaconazole prophylaxis: a systematic review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2025.106535_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.20.00475","article-title":"Immune biology of acute myeloid leukemia: implications for immunotherapy","volume":"39","author":"Khaldoyanidi","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jinf.2025.106535_bib10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.jinf.2025.106535_bib11","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1200\/JCO.2008.21.0856","article-title":"Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve","volume":"27","author":"Portugal","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jinf.2025.106535_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2025.106535_bib13","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3109\/10428194.2012.750723","article-title":"Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia","volume":"54","author":"Kontoyiannis","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.jinf.2025.106535_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00673-19","article-title":"Live monitoring and analysis of fungal growth, viability, and mycelial morphology using the IncuCyte NeuroTrack processing module","volume":"10","author":"Wurster","year":"2019","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.jinf.2025.106535_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1200\/JCO.19.01916","article-title":"D-index\u2013guided early antifungal therapy versus empiric antifungal therapy for persistent febrile neutropenia: a randomized controlled noninferiority trial","volume":"38","author":"Kanda","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jinf.2025.106535_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286089","article-title":"D-index and invasive fungal infections (IFIs) in adult acute myeloid leukemia (AML) patients with the first episode of febrile neutropenia","volume":"18","author":"Rattanathammethee","year":"2023","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jinf.2025.106535_bib17","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/517849","article-title":"Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality\u2014SEIFEM-C report","volume":"44","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106535_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/ijms23020829","article-title":"MicroRNAs as modulators of the immune response in T-cell acute lymphoblastic leukemia","volume":"23","author":"Del Gaizo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jinf.2025.106535_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12964-023-01259-1","article-title":"Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN\/MADD targeting in the NF-\u03baB signaling pathways","volume":"21","author":"Otmani","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jinf.2025.106535_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1000996","article-title":"The cytokine network in acute myeloid leukemia","volume":"13","author":"Luciano","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2025.106535_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772408","article-title":"Inflammatory cytokines shape an altered immune response during myeloid malignancies","volume":"12","author":"Camacho","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2025.106535_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3892\/ol.2012.614","article-title":"Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-\u03b2 in acute myeloid leukemia","volume":"3","author":"Wu","year":"2012","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.jinf.2025.106535_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaci.2017.02.034","article-title":"IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity","volume":"140","author":"Cunha","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2025.106535_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.20.00475","article-title":"Immune biology of acute myeloid leukemia: implications for immunotherapy","volume":"39","author":"Khaldoyanidi","year":"2021","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jinf.2025.106535_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment","volume":"122","author":"Mussai","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2025.106535_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2017.07.018","article-title":"The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells","volume":"22","author":"Gon\u00e7alves Silva","year":"2017","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.jinf.2025.106535_bib27","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.4049\/jimmunol.1500262","article-title":"Defective NK cells in acute myeloid leukemia patients at diagnosis are associated with blast transcriptional signatures of immune evasion","volume":"195","author":"Khaznadar","year":"2015","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jinf.2025.106535_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/jof4040141","article-title":"Development and applications of prognostic risk models in the management of invasive mold disease","volume":"4","author":"Stanzani","year":"2018","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.jinf.2025.106535_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/jof4040137","article-title":"Immunomodulation as a therapy for Aspergillus infection: current status and future perspectives","volume":"4","author":"Lauruschkat","year":"2018","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"10.1016\/j.jinf.2025.106535_bib30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/JCM.05946-11","article-title":"Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay","volume":"50","author":"Tortorano","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2025.106535_bib31","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3389\/fmicb.2018.01612","article-title":"Immunomodulation as therapy for fungal infection: are we closer?","volume":"9","author":"Sam","year":"2018","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2025.106535_bib32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/cid\/ciab1070","article-title":"Investigational antifungal agents for invasive mycoses: a clinical perspective","volume":"75","author":"Lamoth","year":"2022","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344532500129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344532500129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:31:02Z","timestamp":1778945462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344532500129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S016344532500129X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106535","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blastemia portrays a poor prognosis in acute leukemia patients with invasive pulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106535"}}